In what St. Jude hopes will be a happy marriage, it will acquire the heart assist device company in an all cash transaction that represents a significant premium
Companies
Edwards Lifesciences to Acquire CardiAQ™
Edwards Lifesciences Corporation is to acquire privately held CardiAQ™ Valve Technologies, Inc., developer of a transcatheter mitral valve replacement system.
Medtronic’s New Biopsy System Targets Improved Lung Cancer Diagnosis
Medtronic tells us its recently FDA cleared system can get to difficult-to-access areas and collect larger, more intact samples
Mitek Launches New VAPR® RF Arthroscopic Ablation Devices
Company claims a new level of performance, procedural efficiency and safety as devices promise better ablation combined with lower temperature
Data Supports Adhesive for Chronic Venous Insufficiency
12 month closure rates for the VenaSeal™ closure system comparable to radiofrequency ablation
St. Jude’s CardioMEMS HF System Featured at Premier, Inc.’s 2015 ‘Innovation Celebration’ Breakthroughs Conference
CardioMEMS allows patient heart data to be transmitted to health providers who can then manage medication to reduce hospitalization risk
New U.S. Clinical Support for Sorin’s Solo Smart Pericardial Aortic Valve
Solo Smart offers the superior hemodynamics of a stentless valve combined with a stented valve’s ease of implantation
Zimmer and Biomet Deal Done
It’s taken a while, but now the $14 Billion acquisition is final
DePuy Synthes and AO Sign Five Year Cooperation Agreement
55 years and counting: the old Synthes/AO collaboration is cemented for the future
Medtronic Launches GastriSail™ Bariatric Surgery Device
New Bariatric Surgery device makes the most common weight loss procedure in U.S. more consistent and efficient
Size Matters as Smith & Nephew Pulls Smaller Hip Resurfacing Components
Smaller sized Birmingham Hip Resurfacing components are being withdrawn due to heightened risk of revision surgery
Axium™ Trumps Traditional Spinal Cord Stimulation for Chronic Lower Limb Pain Relief
New study data points to St. Jude’s Dorsal Root Ganglion stimulator delivering better pain relief than traditional spinal cord stimulation.
CE Mark for St. Jude’s “Industry First” Neuromodulation Trial System
St. Jude Medical, Inc., has gained CE Mark approval and announced the European launch of its Invisible Trial System, an app-based and wireless neuromodulation programming system leveraging Apple™ iPod touch™ and iPad mini™ technology.
DePuy Synthes Determinedly Integrates into Healthcare Provision
DePuy Synthes is launching its eSIMS Inventory Management and Ordering Solution as well as its Geriatric Fracture Program in the EMEA region
CE Mark for Abbott’s New Absorb GT1™ Stent System
New generation of Abbott’s absorbable stent line features improved access and deliverability
Good Press for St. Jude Medical’s Quadripolar Technology at HRS 2015
Presentations at this year’s HRS event point to improved clinical outcomes, increased survival and better cost utilization with the SJM™ Quadra CRT system